Femme et Homme
- | Pays :
- Bulgaria
- Argentina
- Russian Federation
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to evaluate the safety, tolerability, and efficacy of JNJ-40346527 200 mg/day (100 mg twice daily) for 12 weeks, compared with placebo, in patients with active rheumatoid arthritis (RA) despite disease-modifying antirheumatic drug (DMARD) therapy.
Critère d'inclusion
- Arthritis (rheumatoid)